Bone graft substitute receives CE mark approval: 3 notes

Biologics

Sirakoss received CE mark approval for its Osteo3, a new nano-synthetic bone graft substitute designed for use in bone fracture repair.

Three things to know:

1. Based on Sirakoss' proprietary nano-porous technology, Osteo3 consists of an inorganic matrix designed to be completely reabsorbed into the bone.

2. Osteo3 is intended for use as a bone graft material for filling skeletal system voids or gaps. It can be used alone or in combination with autograft or allograft.

3. Sirakoss is a nano-synthetic bone graft substitute developer.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers